U.S. Food and Drug Administration

New state measures are targeting riced vegetable products to protect the rice industry.

A single study was the main catalyst for recent sunscreen ingredient bans, yet the science community is still debating those ingredients' effects on coral reefs—and even on sunscreen users.

The agency says it is looking into the use of CBD in food as well as deceptive marketing of CBD products.

The agency wants to update food packaging rules so that such labeling is based on scientific evidence.

The FDA cleared the last hurdle for the first GMO fish. Industry groups want pigs to be next.

Scientists have studied the potential for ketamine to treat severe depression for years, but this is the first time the FDA has indicated its use as an antidepressant.

The House Oversight and Reform Committee announced on Monday the launch of an investigation into the pharmaceutical industry's pricing practices.

The Food and Drug Administration is approving a powerful new opioid painkiller, the agency announced Friday.

The agency's new plan retains several key limitations on animal biotechnology, despite language promoting innovation.

After making a tool that tracks how well drug testers follow U.S. law, researchers turned to an even bigger market for drug trials: the European Union.

Federal regulators announce that they will examine the regulation of non-prescription drugs such as acetaminophen, the active ingredient in Tylenol.